ADCT-901
- Generic Name
- ADCT-901
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- ADC Therapeutics S.A.
- Target Recruit Count
- 30
- Registration Number
- NCT04972981
- Locations
- 🇪🇸
Universidad Complutense de Madrid - Hospital Universitario 12 de Octubre, Madrid, Spain
🇬🇧Imperial College Healthcare NHS Trust - St Mary's Hospital, London, England, United Kingdom
🇬🇧Sarah Cannon Research Institute (SCRI) - London (SCRI-UK), London, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath